Imunon Inc (IMNN) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Biotechnology industry.
Historical revenue and profitability trends for Imunon Inc
The chart above illustrates Imunon Inc's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.
Annual percentage change in revenue and earnings
Growth rates provide insight into the momentum of Imunon Inc's business.
How efficiently Imunon Inc converts revenue into profit
Profit margins reveal how much of each dollar of revenue Imunon Inc retains at different stages:
Analyst estimates and forward-looking indicators
Wall Street analysts project Imunon Inc to continue focusing on sustainable operations. The consensus analyst rating is 4.25 based on 4 analysts.
Based on our comprehensive analysis, Imunon Inc (IMNN) demonstrates declining growth characteristics.
This growth analysis provides a comprehensive view of Imunon Inc's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.
See how Imunon Inc stacks up against similar companies
Explore growth analysis for top stocks
Related: IMNN Valuation, IMNN Dividend, IMNN Financial Health
Compare: IMNN vs AAPL, IMNN vs MSFT, IMNN vs GOOGL